Frank E. Thomas
2015
In 2015, Frank E. Thomas earned a total compensation of $1.8M as President and Chief Operating Officer at AMAG Pharmaceuticals, a 19% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $216,700 |
|---|---|
| Option Awards | $524,148 |
| Salary | $474,861 |
| Stock Awards | $618,250 |
| Other | $7,950 |
| Total | $1,841,909 |
Thomas received $618.3K in stock awards, accounting for 34% of the total pay in 2015.
Thomas also received $216.7K in non-equity incentive plan, $524.1K in option awards, $474.9K in salary and $8K in other compensation.
Rankings
In 2015, Frank E. Thomas' compensation ranked 5,059th out of 13,638 executives tracked by ExecPay. In other words, Thomas earned more than 62.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,059 out of 13,638 | 63rd |
Division Manufacturing | 1,864 out of 5,190 | 64th |
Major group Chemicals And Allied Products | 668 out of 1,854 | 64th |
Industry group Drugs | 530 out of 1,528 | 65th |
Industry Pharmaceutical Preparations | 418 out of 1,182 | 65th |
Source: SEC filing on April 20, 2017.
Thomas' colleagues
We found six more compensation records of executives who worked with Frank E. Thomas at AMAG Pharmaceuticals in 2015.
2015
William Heiden
AMAG Pharmaceuticals
Chief Executive Officer
2015
Geoffrey Crouse
AMAG Pharmaceuticals
Chief Executive Officer
2015
Julie Krop
AMAG Pharmaceuticals
Chief Medical Officer
2015
Joseph Vittiglio
AMAG Pharmaceuticals
General Counsel
2015
Kenneth Wilson
AMAG Pharmaceuticals
Former Senior Vice President, Sales and Marketing, and President of Lumara Health Division
2015
Scott Holmes
AMAG Pharmaceuticals